Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
InhaTarget (inhatarget.com) is the official website of Belgian biotech company InhaTarget Therapeutics. Spun out of Vrije Universiteit Brussel, the company was founded in 2019, and focuses on the research and development of innovative targeted inhaled drug delivery formulations for severe respiratory diseases. Its current core R&D focus is innovative treatment solutions for lung cancer. The website fully discloses the company's development history, team background, technology platforms, core pipelines and the latest progress in clinical trials, opening information to industry professionals and investors.
The company's core product is CIS-DPI, a dry powder inhalation formulation modified from the traditional chemotherapy drug cisplatin, which delivers treatment for non-small cell lung cancer directly through pulmonary administration. Compared with conventional intravenous administration, this approach theoretically reduces the systemic side effects of cisplatin, increases local drug concentration in the lungs, and can also activate local anti-tumor immunity. It can be combined with existing immunotherapies to improve treatment efficacy, and patients can even administer the treatment themselves at home, which significantly improves quality of life. The product has already received approval from Belgian regulatory authorities, and is currently undergoing Phase I/IIa human clinical trials at five hospitals in Belgium, with overall development progressing smoothly.
The website can be accessed directly from China, with smooth page loading, clear information structure, and a complete display of the full process of the company's R&D.
This website is mainly intended for researchers in the biopharmaceutical industry, investors in the healthcare sector, and clinicians specializing in lung cancer. It does not currently provide products or clinical services to general Chinese patients.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on inhatarget.com official site.
inhatarget.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach inhatarget.com directly.